National Institute of Mental Health; Notice of Closed Meetings, 80082 [2016-27341]
Download as PDF
<![CDATA[
80082
Federal Register / Vol. 81, No. 220 / Tuesday, November 15, 2016 / Notices
Dated: November 8, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–27336 Filed 11–14–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meetings
mstockstill on DSK3G9T082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Clinical Trials to Test the Effectiveness of
Treatment, Preventive, and Services
Interventions.
Date: November 30, 2016.
Time: 11:30 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Karen Gavin-Evans, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH Neuroscience Center,
6001 Executive Boulevard, Room 6153, MSC
9606, Bethesda, MD 20892, 301–451–2356,
gavinevanskm@mail.nih.gov.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: David I. Sommers, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, National Institutes of Health,
6001 Executive Blvd., Room 6154, MSC 9606,
Bethesda, MD 20892–9606, 301–443–7861,
dsommers@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel,
NIMH Fellowship and Dissertation Research
Review Teleconference.
Date: December 1, 2016.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
22:00 Nov 11, 2016
Jkt 241001
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Vinod Charles, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH Neuroscience Center,
6001 Executive Blvd., Room 6151, MSC 9606,
Bethesda, MD 20892–9606, 301–443–1606,
charlesvi@mail.nih.gov.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: David W. Miller, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH Neuroscience Center,
6001 Executive BLVD, Room 6140, MSC
9608, Bethesda, MD 20892–9608, 301–443–
9734, millerda@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
Dated: November 8, 2016.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–27341 Filed 11–14–16; 8:45 am]
BILLING CODE 4140–01–P
be required to receive copies of the
patent applications.
SUPPLEMENTARY INFORMATION:
Technology descriptions follow.
Immortalized Stria Vascularis Cell Line
SV–k1
Description of Technology
Available for nonexclusive licensing
for research uses is the cell line, SV–k1,
derived from the Organ of Corti. The
line was developed from the stria
vascularis, an organ localized on the
lateral wall of the cochlea, adjacent to
the Organ of Corti, containing cell
populations specialized in the
production of an endolymph very rich
in K+ characteristic of the mammalian
inner ear. SV–k1 cells express a set of
biomarkers completely different of those
expressed by OC–k3 cells (See notice for
E–012–2017/0 published
contemporaneously herewith), and are
not sensitive to ototoxic drugs.
Potential Commercial Applications
• Research
• Hearing research
Development Stage
• Materials
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The inventions listed below
are owned by an agency of the U.S.
Government and are available for
licensing in the U.S. in accordance with
35 U.S.C. 209 and 37 CFR part 404 to
achieve expeditious commercialization
of federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
FOR FURTHER INFORMATION CONTACT:
Licensing information and copies of the
U.S. patent applications listed below
may be obtained by writing to the
indicated licensing contact at the
National Heart, Lung and Blood
Institute, Office of Technology Transfer
and Development, National Institutes of
Health, 31 Center Drive Room 4A29,
MSC2479, Bethesda, MD 20892–2479;
telephone: 301–402–5579. A signed
Confidential Disclosure Agreement may
SUMMARY:
PO 00000
Frm 00068
Fmt 4703
Sfmt 9990
Inventors
Gilda Mabel Canseco de Kalinec and
Federico Kalinec (both of NIDCD).
Publications
1. Espreafico, EM et al., ‘‘Localization of
Myosin-V in the Centrosome’’
(1998) Proc Nat’l Acad Sci USA
95(15):8636–8641, 1998.
2. Gratton MA et al., ‘‘Strial marginal
cells play a role in basement
membrane homeostasis: In vitro and
in vivo evidence.’’ Hear Res
163:27–36, 2002.
3. Park, C., et al., ‘‘HEl-OC1 Cells as a
Model for Investigating Prestin
Function.’’ (2016) Hear Res 335:9–
17.
Intellectual Property
HHS Reference No. E–013–2017/0—
Research Material.
Licensing Contact
Michael Shmilovich, Esq, CLP; 301–
435–5019; shmilovm@mail.nih.gov.
Dated: November 7, 2016.
Michael Shmilovich,
National Heart, Lung and Blood Institute,
Office of Technology Transfer and
Development, National Institutes of Health.
[FR Doc. 2016–27337 Filed 11–14–16; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\15NON1.SGM
15NON1
]]>Agencies
[Federal Register Volume 81, Number 220 (Tuesday, November 15, 2016)]
[Notices]
[Page 80082]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-27341]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Mental Health Special
Emphasis Panel; Clinical Trials to Test the Effectiveness of
Treatment, Preventive, and Services Interventions.
Date: November 30, 2016.
Time: 11:30 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6100 Executive Boulevard,
Rockville, MD 20852, (Telephone Conference Call).
Contact Person: Karen Gavin-Evans, Ph.D., Scientific Review
Officer, Division of Extramural Activities, National Institute of
Mental Health, NIH Neuroscience Center, 6001 Executive Boulevard,
Room 6153, MSC 9606, Bethesda, MD 20892, 301-451-2356,
gavinevanskm@mail.nih.gov.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: David I. Sommers, Ph.D., Scientific Review
Officer, Division of Extramural Activities, National Institute of
Mental Health, National Institutes of Health, 6001 Executive Blvd.,
Room 6154, MSC 9606, Bethesda, MD 20892-9606, 301-443-7861,
dsommers@mail.nih.gov.
Name of Committee: National Institute of Mental Health Special
Emphasis Panel, NIMH Fellowship and Dissertation Research Review
Teleconference.
Date: December 1, 2016.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852, (Telephone Conference
Call).
Contact Person: Vinod Charles, Ph.D., Scientific Review Officer,
Division of Extramural Activities, National Institute of Mental
Health, NIH Neuroscience Center, 6001 Executive Blvd., Room 6151,
MSC 9606, Bethesda, MD 20892-9606, 301-443-1606,
charlesvi@mail.nih.gov.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852, (Telephone Conference
Call).
Contact Person: David W. Miller, Ph.D., Scientific Review
Officer, Division of Extramural Activities, National Institute of
Mental Health, NIH Neuroscience Center, 6001 Executive BLVD, Room
6140, MSC 9608, Bethesda, MD 20892-9608, 301-443-9734,
millerda@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program No. 93.242, Mental
Health Research Grants, National Institutes of Health, HHS)
Dated: November 8, 2016.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-27341 Filed 11-14-16; 8:45 am]
BILLING CODE 4140-01-P
